Psoriasis
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Psoriasis trials.

Effective solutions for advancing Psoriasis research

Psoriasis is a common autoimmune skin disease affecting 3 million people in the US alone. This chronic condition often negatively impacts the physical, psychosocial, and emotional wellbeing of patients. While there currently is no cure for the condition, today's treatments can help manage symptoms and improve the quality of life for people living psoriasis. Signant SmartSignals digital solutions and our team of experts help psoriasis clinical trials generate reliable, high-quality evidence for informed decisions and advanced treatments.

Psoriasis-1

Why Signant Health

  • Collect Accurate Data
  • Safeguard Study Data
  • Standardize Rater Training
  • Deliver Treatments on Time
  • Prevent Placebo Response
  • Gain Objective Measures
  • Collect Accurate Data

    Collect Accurate Data

    Our customizable eCOA solution accommodates the electronic administration of both at-home patient assessments, such as diaries measuring itch and pain, and on-site validated, disease-specific clinician assessments, such as the Psoriasis Area and Severity Index (PASI). Each assessment or diary entry is stamped with the time and date to prove data was collected within the protocol's desired window.
     
     

  • Safeguard Study Data

    Safeguard Study Data

    Signant's Blinded Data Analytics solution uses proprietary algorithms to identify data quality concerns at all relevant levels. Our supportive team of in-house experts are there every step of the way to make recommendations to correct and prevent reoccurrence of data quality issues.
     

  • Standardize Rater Training

    Standardize Rater Training

    Our customizable rater training program standardizes the administration of ClinROs, such as the Psoriasis Area and Severity Index (PASI). Designed and implemented by experienced clinician raters, our rater training curriculum standardizes assessment techniques, and establishes scale anchor points to increase the accuracy and reliability of ratings.

  • Deliver Treatments on Time

    Deliver Treatments on Time

    Our Randomization & Trial Supply Management (RTSM) solution ensures the right medication reaches patients at the right time - and with an optimized shelf life. The tool's modern interface provides study teams with key reports for optimal visibility into study KPIs.
     
     

  • Prevent Placebo Response

    Prevent Placebo Response

    We recommend adding our placebo response mitigation training to reduce augmentation of the placebo response among investigators, site personnel, and patients. 

  • Gain Objective Measures

    Gain Objective Measures

    Objective sleep quality and activity measures can help support your findings during the regulatory process. By integrating Actigraph sensors with our eCOA solution, study teams will gain insights into a psoriasis patient's function and quality of life without burdening patients or sites.
     

Comprehensive Psoriasis Experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Psoriasis trial resources
SOLUTION BROCHURE

Psoriasis Trial Solutions Overview


GET INSIGHTS
VIDEO

Psoriasis Trial Solutions



WATCH [2 MIN]
SOLUTION

Rater Training & Qualification


 
LEARN MORE

Ready to learn more?

Discover how Signant can support your current or upcoming psoriasis trials.